Xtx Topco LTD Tg Therapeutics, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.32 - $19.19 $295,384 - $425,557	22,176 New	22,176 $394,000
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $38,648 - $122,509	4,623 Added 30.07%	19,999 $167,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $238,020 - $538,160	15,376 New	15,376 $381,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $90,771 - $214,335	-18,118 Reduced 50.59%	17,695 $209,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $5,511 - $10,130	-1,206 Reduced 3.26%	35,813 $212,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $138,451 - $394,622	37,019 New	37,019 $157,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.